Cointime

Trophos

company

About

Trophos is a clinical stage pharmaceutical company developing innovative therapeutics for indications with under-served needs in neurology

  • 11 - 50

Highlights

Total Funding Amount
€8.50M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series C
Last Funding Money Raised
€8.50M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 1998
Number Of Employee
11 - 50
Operating Status
Active

Trophos is a clinical stage pharmaceutical company developing innovative therapeutics for indications with under-served needs in neurology and cardiology.

Trophos is a fully integrated clinical stage company with a pipeline of original molecules in development for the motoneuron diseases amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and spinal muscular atrophy (SMA), chemotherapy-induced peripheral neuropathy, cardiac ischemia-reperfusion injury and other neurological conditions.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€8.50M
Trophos has raised a total of €8.50M in funding over 2 rounds. Their latest funding was raised on Sep 5, 2007 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 5, 2007 Series C €8.50M 1 Apicap — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Trophos is funded by 1 investors. Apicap are the most recent investors.
Investor Name Lead Investor Funding Round
Apicap Yes Series C
Cointime
เนื้อหา
บริษัท